Antibodies to voltage-gated calcium channels in children with falciparum malaria

Journal of Infectious Diseases

Volumn 191, Issue 1, 2005, Pages 117-121

  Lang, Bethan ^a   Newbold, Christopher I ^a   Williams, Graham ^a   Peshu, Norbert ^c   Marsh, Kevin ^c   Newton, Charles R J C ^b,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BRAIN MALARIA; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; KENYA; MALARIA FALCIPARUM; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; CALCIUM CHANNELS; CHILD; COHORT STUDIES; HUMANS; KENYA; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM;

EID: 11144306887     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/426512     Document Type: Article

References (16)

1. Newton CRJC, Krishna S. Severe falciparum malaria in children: current understanding of its pathophysiology and supportive treatment. Pharmacol Ther 1998;79:1-53.
2. Carter JA, Neville BGR, White S, et al. Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia 2004;45:978-81.
3. Lang B, Dale RC, Vincent A. New autoantibody mediated disorders of the central nervous system. Curr Opin Neurol 2003;16:351-7.
4. Palace J, Lang B. Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 2000;69:711-4.
5. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12.
6. World Health Organization. Severe and complicated malaria. Trans R Soc Trop Med Hyg 2000;94(Suppl 1):S1-74.
7. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Geneva: World Health Organization, 1993:1-61.
8. Vincent A. Measuring and evaluating the significance of autoantibodies in neurological disorders. Clin Appl Immunol Review 2002;3:127-51.
9. Motomura M, Johnston I, Lang B, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35-42.
10. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q-type calcium channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002;59:764-6.
11. Pinto A, Iwasa K, Newland C, Newsom-Davis J, Lang B. Action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels. Muscle Nerve 2002;25:715-24.
12. el Far O, Marqueze B, Leveque C, et al. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome. J Neurochem 1995;64:1696-1702.
13. Brown H, Rogerson S, Taylor T, et al. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg 2001;64:207-13.
14. Badibanga B, Dayal R, Depierreux M, Pidival G, Lambert PH. Etude des principaux facteurs immunologiques et de la barriere hemato-meningee au cours de la malaria cerebrale chez l'enfant en pays d'endemie (Zaire). Ann Soc Belg Med Trop 1986;66:23-37.
15. Mturi N, MacClennan C, Keir G, Newton CRJC. The blood brain barrier is mildly impaired in Kenyan children with severe falciparum malaria. J Cereb Blood Flow Metab 2003;23(Suppl 1):163.
16. de Silva HJ, Hoang P, Dalton H, de Silva NR, Jewell DP, Peiris JB. Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1992;86:12-3.